Skip to main content

Table 2 MOH clusters characterisation

From: Insights into the clinical management of the syndrome of supine hypertension – orthostatic hypotension (SH-OH): The Irish Longitudinal Study on Ageing (TILDA)

 

MOH-1

MOH-2

MOH-3

P

Small drop, overshoot

Medium drop, just recovery

Large drop, non-recovery

 

N= 1,456

N= 2,230

N= 781

 

Systolic blood pressure (SBP)

    

Baseline SBP (mmHg)

130.4 (20.7)

137.2 (21.3)

144.9 (24.9)

<0.001 Σ

∆ SBP (mmHg)

−24.1 (10.8)

−40.2 (9.9)

−64.8 (15.2)

<0.001 Σ

Nadir SBP (mmHg)

106.3 (22.0)

97.0 (22.1)

80.1 (24.5)

<0.001 Σ

SBP by 30 s (mmHg)

143.1 (22.9)

133.8 (23.0)

122.9 (28.7)

<0.001 Σ

SBP by 30 s (% baseline)

110.0 (8.1)

97.5 (6.6)

84.5 (11.4)

<0.001 Σ

SBP by 60 s (mmHg)

142.5 (23.4)

134.0 (23.2)

125.8 (28.9)

<0.001 Σ

SBP by 60 s (% baseline)

109.5 (8.2)

97.6 (6.6)

86.6 (11.5)

<0.001 Σ

SBP by 90 s (mmHg)

142.9 (23.3)

135.3 (23.0)

127.3 (30.0)

<0.001 Σ

SBP by 90 s (% baseline)

109.9 (8.8)

98.7 (7.1)

87.7 (13.0)

<0.001 Σ

SBP by 110 s (mmHg)

143.2 (23.5)

135.3 (22.8)

126.5 (30.7)

<0.001 Σ

SBP by 110 s (% baseline)

110.1 (9.1)

98.7 (7.1)

87.1 (13.6)

<0.001 Σ

Diastolic blood pressure (DBP)

    

Baseline DBP (mmHg)

70.7 (10.4)

74.0 (10.7)

76.4 (13.1)

<0.001 Σ

∆ DBP (mmHg)

−18.5 (7.8)

−26.4 (7.5)

−37.5 (9.7)

<0.001 Σ

Nadir DBP (mmHg)

52.2 (12.3)

47.5 (12.8)

38.9 (14.6)

<0.001 Σ

DBP by 30 s (mmHg)

75.6 (11.6)

72.3 (12.2)

66.0 (16.0)

<0.001 Σ

DBP by 90 s (mmHg)

75.9 (11.3)

73.1 (11.7)

68.3 (15.2)

<0.001 Σ

DBP by 90 s (mmHg)

75.7 (11.0)

73.3 (11.6)

68.6 (15.6)

<0.001 Σ

DBP by 110 s (mmHg)

75.8 (11.3)

73.1 (11.5)

68.0 (15.7)

<0.001 Σ

Heart rate (HR)

    

Baseline HR (bpm)

66.4 (10.0)

65.3 (10.0)

63.1 (10.0)

<0.001 Σ

∆ HR (bpm)

20.6 (8.6)

19.8 (8.8)

18.4 (9.5)

<0.001 Σ

Nadir HR (bpm)

87.0 (12.6)

85.1 (13.1)

81.5 (14.2)

<0.001 Σ

HR by 30 s (bpm)

72.6 (11.4)

72.2 (11.8)

69.7 (12.2)

<0.001 Σ

HR by 60 s (bpm)

74.1 (11.4)

74.1 (11.5)

71.8 (12.2)

<0.001 Σ

HR by 90 s (bpm)

73.1 (10.9)

73.1 (11.2)

71.0 (11.9)

0.001 Σ

HR by 110 s (bpm)

73.1 (10.9)

73.2 (11.1)

71.0 (11.9)

0.001 Σ

Orthostatic intolerance and blackouts/faints

    

OI symptoms during active stand (%)

33.1

39.4

44.9

<0.001 χt

Ever had a blackout or fainted (%)

17.8

20.2

21.6

0.07χt

Demographics

    

Age

61.2 (8.1)

61.2 (8.1)

63.6 (9.0)

<0.001 Σ

Age range

50 - 89

50 - 90

50 - 91

-

Female gender (%)

48.8

53.4

64.4

<0.001 χt

Medications

    

Polypharmacy (5 or more meds) (%)

16.7

16.8

21.0

0.02χt

On cardiac glycosides (e.g. digoxin) (C01A) (%)

0.8

0.8

0.5

0.76χt

On antiarrhythmics class I and III (C01B) (%)

0.2

0.4

0.4

0.58χt

On beta-blocker (C07A) (%)

10.4

10.4

15.7

<0.001 χt

On diuretic (C03) (%)

6.2

5.7

6.5

0.66χt

On ACE-i (C09A) (%)

10.1

10.9

9.7

0.58χt

On ARA (C09C) (%)

7.8

6.8

7.2

0.48χt

On calcium channel blocker – with mainly vascular effects (C08C) (%)

7.3

7.3

6.4

0.66χt

On calcium channel blocker – with direct cardiac effects (C08D) (%)

1.0

1.3

1.5

0.44χt

On peripherally acting anti-adrenergic (e.g. alpha-blocker) (C02C) (%)

0.7

1.8

2.3

0.004 χt

On cardiac vasodilator (e.g. nitrates) (C01D) (%)

1.0

1.2

1.7

0.35χt

On peripheral vasodilator (C04A) (%)

0.2

0.2

0.3

0.92χt

On antiepileptic (N03A) (%)

1.8

2.5

2.4

0.33χt

On antipsychotic (N05A) (%)

0.8

0.9

1.8

0.07χt

On anxiolytics (N05B) (%)

1.2

1.6

2.7

0.03χt

On hypnotics or sedatives (N05C) (%)

3.4

3.3

4.4

0.36χt

On antidepressant (N06A) (%)

4.0

5.7

10.2

<0.001 χt

Comorbidities

    

Hypertension (%)

32.1

32.4

35.3

0.25χt

Angina (%)

4.3

3.9

5.9

0.07χt

Heart attack (%)

4.3

3.9

3.3

0.51χt

Heart failure (%)

0.7

0.9

0.6

0.59χt

Diabetes (%)

7.4

6.1

5.9

0.21χt

Stroke (%)

1.2

1.1

1.3

0.89χt

TIA (%)

1.3

1.7

1.7

0.56χt

Abnormal heart rhythm (%)

6.5

7.4

7.3

0.61χt

Parkinson’s disease (%)

0.1

0.4

0.5

0.13χt

3 or more chronic diseases (%)

23.2

23.7

26.9

0.13χt

Disability

    

Any IADL disability (%)

3.2

3.8

5.2

0.06χt

Cognition

    

MMSE score

28.6 (2.0)

28.7 (1.7)

28.6 (1.6)

0.18Σ

  1. Σ Spearman’s rank correlation coefficient; χt Chi-squared test for trend.